Project Grant R36AG088283
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$104K
Federal Agency
National Institute on Aging
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $528,876 to Emory University to investigate the cis- and trans-genetic regulation of brain transcriptomics and proteomics associated with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The project aims to develop new analytical tools that can leverage genomic data from multiple tissues to identify additional AD risk genes and better understand their underlying molecular...
This $1,938,189 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research into the mechanisms and toxicity of chimeric dipeptide repeat (CDPR) proteins in C9-related amyotrophic lateral sclerosis (C9ALS) and frontotemporal dementia (C9FTD). The research aims to: 1) identify the complexity, extent, and mechanism of CDPR pathology in C9ALS/FTD, 2) investigate the molecular consequences and neuronal toxicity of specific CDPR species in vitro...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $460,625 to Yale University to elucidate the molecular mechanisms by which the protein TBK1 coordinates lysosome function with cellular demand. The research aims to understand how mutations in TBK1 and C9ORF72 genes, which cause amyotrophic lateral sclerosis and frontotemporal dementia, disrupt lysosome regulation and functions in neurons and glia. The study will use genome-edited cell lines,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $1,118,700.00 will fund research by New York University School of Medicine to investigate the role of pathological tau protein in disrupting the endosomal microautophagy (EMI) pathway. The proposed experiments aim to elucidate how tau pathology leads to impairment of the EMI pathway, which is crucial for protein quality control and neuronal function. The research will manipulate key...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,001,864 to Harvard University to investigate the subcellular mechanisms underlying the selective vulnerability of specific neuron subtypes in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The researchers will quantitatively study the localization of RNA, proteins, and translational regulation in the synapses and soma of vulnerable corticospinal neurons (CSN) and...
This federal Project Grant award, with ID R01AG092468, was provided by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866). The $913,225 award supports research to systematically characterize proteinopathies, such as amyloid-beta, tau, alpha-synuclein, and TDP-43, as well as U1 small nuclear ribonucleoprotein (U1 SNRNP) dysfunction and associated splicing abnormalities in Alzheimer's disease (AD) and AD-related dementias (ADRD). The research, led by...
The National Institute on Aging (NIA) awarded a $498,748 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of Massachusetts Medical School (UMass Medical) in Worcester, MA. The grant, effective September 1, 2024 through August 31, 2025, will fund research to elucidate the mechanisms by which genes in the membrane-spanning 4A (MS4A) gene family regulate neurodegeneration in Alzheimer's disease, frontotemporal dementia, multiple sclerosis, and amyotrophic...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $147,656 to Emory University to develop the first human locus coeruleus (LC) organoid model to study the role of the LC in the earliest stages of Alzheimer's disease (AD). The key products and services to be delivered include: Validating the structure and function of the LC organoids by comparing them to human and rodent LC neurons. 2) Combining the LC organoids with cortical organoids to define...
The National Institute on Aging (NIA) awarded a $630,496 Project Grant under the Aging Research program (CFDA 93.866) to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, CA. The grant, which runs from June 1, 2025 to March 31, 2030, supports research into the proteostasis, neuroinflammation, and neurodegeneration mechanisms underlying frontotemporal dementia (FTD) caused by GRN haploinsufficiency. Key objectives include defining the alterations...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $3,841,367 to The Regents of the University of California, San Francisco to conduct research on the role of the TBK1 protein kinase in regulating selective autophagy pathways and maintaining neural proteostasis. The goal is to gain a comprehensive understanding of how disruption of TBK1 and its interactions with cargo receptors like optineurin leads to the neurodegeneration...